Articles about Omeros

GeekWire Awards: Billion-dollar deals, rare IPO, pharma pact, and mega-round vie for Deal of the Year

Billion-dollar deals from OpenAI, Novo Nordisk, and Palo Alto Networks are among the finalists for the Deal of the Year in the 2026 GeekWire Awards, alongside a rare Seattle-area IPO and a $5 billion mega-round. Read More

Tech Moves: Microsoft CMO joins 3D printing startup board; Omeros names medical chief

— Somerville, Mass.-based 3D printer company Formlabs appointed Microsoft Chief Marketing Officer Chris Capossela to its board of directors. Capossela has spent more than… Read More

Omeros sells eye surgery product to Rayner for $126M in cash

Seattle biotech Omeros completed a deal Thursday to sell Omidria, a product used in eye surgery, to Rayner Surgical Group.… Read More

Shares of Seattle biotech firm Omeros spike after reporting COVID-19 treatment results

Omeros stock shot up more than 60% after the Seattle-based biotech company reported promising results from its COVID-19 drug treatment.… Read More

Biotech company Omeros and former exec battling in court over non-compete deal and bonuses

Omeros, one of Seattle’s biggest biotech companies, is in the midst of a contentious legal battle with its former chief… Read More

Why Seattle’s Omeros continues to be dogged by questions over its next big drug

Omeros, one of Seattle’s biggest biotech companies, may have its hands on a lucrative new drug — but questions about… Read More

Omeros looks to raise $70M in stock offering to fuel drug development pipeline

The Omeros Corporation, one of Seattle’s biggest biotech companies, is looking to raise approximately $70 million in a follow-on public… Read More